A digital image of DNA

Functional Genomics Network

The Imperial Excellence in Functional Genomics Network builds a cohesive, multi-faculty community that bridges academic, clinical, and research domains.

Translating genomic data into meaningful clinical insights and outcomes remains one of the greatest challenges in modern biomedical research. A key bottleneck is the functional validation of potential disease-causing variants—an essential but resource-intensive step that slows discovery and limits translational impact.

At Imperial London, world-class expertise in computational biology, experimental genetics, and clinical research thrives across departments. Yet, much of this expertise remains siloed, limiting opportunities for collaboration and innovation.

The Imperial Excellence in Functional Genomics Network was established to address this challenge by building a cohesive, multi-faculty community that bridges academic, clinical, and research domains. Our goal is to unify Imperial’s diverse strengths in genomics to enhance collaboration, streamline resources, and accelerate the translation of genetic discoveries into improved patient care.

Our mission

  • Connect experts across the College – From sequence analysis to therapeutic development, we foster collaboration among researchers working at every stage of the genomic research pipeline including clinicians, computational biologists, molecular biologists, bioengineers, chemists alike.
  • Establish focused working groups – Targeting critical areas including but not limited to variant prioritisation, disease modelling, phenotyping, genome editing, and iPSC generation.
  • Develop collaborative pipelines and shared platforms – Standardised assays, streamlined workflows, and accessible tools to enhance reproducibility and knowledge-sharing.
  • Enable training opportunities – Workshops and other training opportunities to enhance the technical capabilities.

Through this unified effort, we aim to accelerate discoveries, improve diagnostics and therapeutics, and advance the future of precision medicine together.